Multiple Socioeconomic Circumstances and Initiation of Cardiovascular Medication among Ageing Employees

Aino Salonsalmi, Elina Mauramo, Eero Lahelma, Ossi Rahkonen and Olli Pietiläinen
Additional contact information
Aino Salonsalmi: Department of Public Health, University of Helsinki, 00014 Helsinki, Finland
Elina Mauramo: Department of Public Health, University of Helsinki, 00014 Helsinki, Finland
Eero Lahelma: Department of Public Health, University of Helsinki, 00014 Helsinki, Finland
Ossi Rahkonen: Department of Public Health, University of Helsinki, 00014 Helsinki, Finland
Olli Pietiläinen: Department of Public Health, University of Helsinki, 00014 Helsinki, Finland

IJERPH, 2021, vol. 18, issue 19, 1-13

Abstract: There are persisting socioeconomic differences in cardiovascular diseases, but studies on socioeconomic differences in the initiation of cardiovascular medication are scarce. This study examined the associations between multiple socioeconomic circumstances and cardiovascular medication. The Helsinki Health Study baseline survey (2000–2002) of 40–60-year-old employees was linked with cardiovascular medication data from national registers. The analyses included 5805 employees concerning lipid medication and 4872 employees concerning hypertension medication. Medication purchases were followed for 10 years. The analyses were made using logistic regression, and the odds ratios (ORs) and their 95% confidence intervals (CIs) were calculated for childhood, conventional and material socioeconomic circumstances. Low parental education showed an association with lipid medication among women only (OR 1.34, 95% CI 1.11–1.61), whereas childhood economic difficulties showed more widespread associations. Low education and occupational class were associated with an increased risk of both hypertension (education: OR 1.58, 1.32–1.89; occupational class: 1.31, 1.08–1.59) and lipid medication (education: 1.34, 1.12–1.61; occupational class: 1.38, 1.13–1.67). Rented housing (1.35, 1.18–1.54 for hypertension medication; 1.21, 1.05–1.38 for lipid medication) and current economic difficulties (1.59, 1.28–1.98 for hypertension medication; 1.35, 1.07–1.71 for lipid medication) increased the risk. Several measures of socioeconomic circumstances acting at different stages of the life course were associated with cardiovascular medication, with individuals in disadvantageous socioeconomic circumstances having elevated risks.

Keywords: socioeconomic factors; cardiovascular diseases; lipid medication; hypertension medication (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/18/19/10148/pdf (application/pdf)
https://www.mdpi.com/1660-4601/18/19/10148/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:18:y:2021:i:19:p:10148-:d:644276

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().